Canopy Growth (CGC) Net Cash Flow Growth (1y) (2020 - 2025)
Canopy Growth (CGC) Net Cash Flow Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -1,020.00% |
| 10 | Canopy Growth | 276.52 Mn | 10.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 548.28% |
| Jun 30, 2025 | 31.67% |
| Dec 31, 2024 | 42.70% |
| Sep 30, 2024 | 109.64% |
| Jun 30, 2024 | 110.97% |
| Mar 31, 2024 | -98.37% |
| Dec 31, 2023 | 49.03% |
| Sep 30, 2023 | -238.26% |
| Jun 30, 2023 | 65.08% |
| Mar 31, 2023 | -18.10% |
| Dec 31, 2022 | 5.87% |
| Sep 30, 2022 | -5.39% |
| Jun 30, 2022 | 56.68% |
| Mar 31, 2022 | -19.63% |
| Dec 31, 2021 | -216.75% |
| Sep 30, 2021 | 184.78% |
| Jun 30, 2021 | -122.13% |
| Mar 31, 2021 | 238.18% |
| Dec 31, 2020 | -62.20% |
| Sep 30, 2020 | 58.93% |